We describe the use of yeast surface display for the identification of antibodies that bind the plasma membranes of living cells. Yeast panning with a nonimmune human singlechain antibody library identified 34 unique lead antibodies that bind (K d ¼ 82 ± 15 nM) and in some cases internalize into rat brain endothelial cells. In addition, we used a new yeast display immunoprecipitation procedure for initial characterization of the cognate antigens.
The ability to merge antibody display libraries with intact cells or tissues for the identification of antibodies that bind to cell membranes has the potential to enable a wide range of applications that include membrane proteomics, selective tissue targeting and intracellular delivery of therapeutic payloads. Such cell-based screening of antibody libraries has been successful in identifying antibodies that target tumors [1] [2] [3] , vascular beds 4 and cellular endocytosis systems 2, 5 . The vast majority of these selections have used phage display techniques, whereas cell-based selections using alternative display platforms have lagged behind 6 . However, we recently demonstrated that yeast display has beneficial attributes such as low levels of nonspecific interaction and multivalent display that could in principle provide the basis for efficient cell-surface selections from synthetic or nonimmune antibody libraries 7 .
To validate the applicability of yeast-surface display for cellsurface antibody selections, we screened a nonimmune yeast display library consisting of B10 9 human single-chain antibody (scFv) clones 8 for antibodies that bind to the plasma membranes of brain endothelial cells. We chose brain endothelial cells as a relevant cellular target because they comprise the blood-brain barrier and act as a selectively permeable interface whose plasma membranes are particularly important in separating the circulation from the brain interior. We panned the nonimmune human scFv yeast library against confluent rat brain endothelial cells (RBE4 cell line 9 , Supplementary Methods online) for five rounds of binding, washing, clone recovery and amplification. After four rounds of panning, there was a clear enrichment in the number of binding yeast ( Fig. 1a and Table 1 ). The recovery percentages of yeast applied to the RBE4 monolayers increased from 18% after round 4 to 78% after round 5. The totals after round 5 indicate that the recovered pool from round 4 consisted almost exclusively of binding yeast as on average only 70-80% of the yeast applied to the monolayer were actually displaying antibody, primarily as a result of plasmid stability effects 10 . Subsequent examination of 12 individual yeast scFv clones recovered from round 4 confirmed the high percentage recovery of binding yeast in that all 12 clones bound specifically to RBE4 cells (Fig. 1b and Table 1 ).
To analyze scFv clones on a larger scale and to reduce the characterization of redundant scFv, we used a high-throughput method that led to the identification of 11 unique RBE4-binding scFv out of 66 clones analyzed (Fig. 1c , scFv clones were named scFvA-K and grouped into six homologous classes, Supplementary Table 1 online). When performing a screen against multiple cellsurface antigens simultaneously, certain scFv clones can dominate the selection as a result of differential antigen abundance, antigenicity or antibody-antigen affinity characteristics 1, 3, 11 , thereby masking the diversity of the binding pool. Indeed, two homologous scFv classes (class 1: scFvA, scFvB, scFvC, scFvG and scFvK and class 2: scFvD and scFvI; Supplementary Table 1) predominated and together represented 61 of the initial 66 clones analyzed, and further mining of the original pool for unique RBE4-binding scFv, although possible, would have been quite laborious. Instead we used the VHCDR2 regions for the class 1 and 2 scFv, which were fully conserved within their respective classes, as yeast colony northern blotting targets for rapid, high-throughput subtractive prescreening of 2,000 clones from the round 4 binding pool (Fig. 1c) . Then we fed only those clones not part of classes 1 or 2 through the cell-based screen. The subtractive approach increased the number of unique scFv to 34, and the number of homology-based binding classes increased to 18 (Supplementary Table 1 ). In total, 88% of the yeast clones in pool 4 were identified as binders with zero instances of binding that was not scFv-mediated. The selected scFv had germline origins that were largely heavy chains VH3 (6 of 18 classes) and VH6 (6 of 18 classes) and light chains Vl1 (11 of 18 classes) and VkIII (4 of 18 classes; Supplementary Table 1) , much like that found in the original, nonselected library in which VH3, VH6 and VkIII were found at the highest frequency 8 . Similar to the reported results for when the same library was used for scFv selections against soluble antigens 8 , we recovered Vl1 at an inordinately high frequency compared with the levels of Vl1 found in the nonselected library. Thus, the light and heavy chain usage for scFv selected against an array of cell surface antigens mimics that found for selection against soluble antigens, and suggests a similar scFv 'fitness' for either form of antigen presentation.
Next we evaluated the class 1, 2 and 3 scFv for their properties as soluble scFv proteins. We subcloned the scFv genes encoding scFvA-K (excluding single domain VH isolates, scFvE and scFvJ) into an scFv expression vector 12 , and they were secreted efficiently from yeast (Fig. 2a) . We then used scFv-containing supernatants and/or purified antibody to immunolabel RBE4 cells and found that each scFv possessed cell-surface binding capacity (Fig. 2) . Class 1 scFv exhibited a clear binding signal with either supernatant or purified material at 3-4 mg/ml, but class 2 (scFvD) and 3 scFv (scFvF) required approximately tenfold higher purified concentrations of 20-80 mg/ml to yield cell surface immunolabeling. Next we used purified scFv to assess the binding affinity to live RBE4 cells. Class 1 scFvA possessed an affinity of K d ¼ 82 ± 15 nM, whereas we could not determine the affinity of class 2 scFvD as a monomeric protein using this method (Fig. 2b) . Instead we evaluated the binding properties of scFvD after predimerization with an epitope tag antibody (avidity ¼ 2.0 ± 0.1 nM). As a comparison, the affinity of an anti-transferrin receptor scFv isolated using a phagemid panning approach was reported to be 135 nM (ref. 2) , of similar affinity to scFvA isolated with our yeast panning system.
To assess the nature of the antigens recognized by the scFv, we developed a new yeast immunoprecipitation procedure. We used yeast displaying scFv to directly immunoprecipitate the cognate plasma membrane antigens from detergent-solubilized, biotinylated RBE4 lysates. Conveniently, the use of yeast as the immunoprecipitation particle allowed the sizing of antigens without any additional subcloning, production or immobilization of scFv proteins required by traditional immunoprecipitation methods. We assessed the immunoprecipitated products by anti-biotin western blotting (Fig. 2c) , and the low amount of background in such blots was a direct indicator of the specificity of the immunoprecipitation process. The antigens immunoprecipitated by class 1 scFvA (124 kDa, nonreduced and several large molecular weight bands, reduced), class 2 scFvD (104 kDa, nonreduced and 117 kDa, reduced) and class 6 scFvJ (122 kDa, nonreduced and 127 kDa, reduced) were distinct (Fig. 2c) . As predicted by the homologybased scFv class assignment, other class 1 scFv (scFvB, scFvC) yielded immunoprecipitation products identical to those seen for scFvA, and class 2 scFvI like that observed for class 2 scFvD (data not shown). The multiple bands appearing in the reduced scFvA sample suggest that along with the antigen recognized specifically by scFvA, coimmunoprecipitation of other biotinylated members of a protein complex or possibly multiple specific antigens may be occurring.
Antibodies that target molecular endocytosis systems are often desired because they can be used for delivering intracellular payloads for a variety of applications. With this in mind, we evaluated several of the class 1, 2 and 3 scFv for their ability to mediate cellular internalization. The scFv were predimerized with an epitope tag antibody to provide the bivalency often required for receptor clustering and endocytosis, and subsequently applied to living RBE4 cells (Fig. 2d) . Class 1 scFvA was rapidly endocytosed into vesicular structures within the RBE4 cells, whereas class 2 scFvD and class 3 scFvF bound the RBE4 surface but did not promote internalization ( Fig. 2d and data not shown). As a comparison, the anti-transferrin receptor monoclonal antibody (OX26) that is known to endocytose and transcytose across the blood-brain barrier 13 was also internalized into RBE4 cells, albeit primarily into single putative endosomal structures (Fig. 2d) . From the standpoint of downstream antibody applications, endocytosing and transcytosing antibodies against the transferrin and insulin receptors have been (2) and washed. A simple light microscopy test was then applied. If induced yeast were retained after washing steps, but not when they were grown in the absence of galactose, the clone was defined as binding (3 versus 4). The gene encoding the binding scFv clone was then amplified directly from the yeast colony (5) and digested with BstNI (6). ScFv with unique digestion patterns were sequenced. IgBLAST and the Kabat database were used for CDR assignment and human germline classification (7). For subtraction screens, this sequence data were used with yeast colony northern blotting to create a depleted pool to send through the analysis (8). 
